Medicine Canada

388 readers

2 active

0 users here now

A community for Canadian physicians and medical professionals

🍁 While this community is intended for Canadian discussions, you are free to post about other medical systems. We're all in this together :)

Related Communities

For better links and descriptions, see the pinned post in the Medical Community Hub (!medicine@lemmy.world)

Rules

No requests for professional advice or general medical information. Please do not solicit medical advice or share personal health anecdotes about yourself or others.
No promotions, advertisements, surveys, or petitions.
Link to high-quality, original research whenever possible: Posts which rely on or reference scientific data (e.g. an announcement about a medical breakthrough) should link to the original research in peer-reviewed medical journals or respectable news sources as judged by the moderators. Sensationalized titles, misrepresentation of results, or promotion of blatantly bad science may lead to removal.
Act professionally and decently: /r/medicine is a public forum that represents the medical community and comments should reflect this. Please keep disagreement civil and focused on issues.
Protect patient confidentiality. Please anonymize cases and remove any patient-identifiable information.
No memes or low-effort posts: Memes, image links (including social media screenshots), images of text, or other low-effort posts or comments are not allowed.

These rules have been modelled after /r/medicine. While some rules were modified or skipped as this is a much smaller community, we can revisit the rules as we go. Thank you :)

founded 3 years ago

moderation log

moderators

otter@lemmy.ca

Dadifer@lemmy.world

Health Canada considering using decisions of foreign regulators for some drug approvals (www.theglobeandmail.com)

submitted 9 months ago by rss@ibbit.at [B] to c/medicine@lemmy.ca

2 comments fedilink hide all child comments

Some experts warn that relying on the decisions of foreign drug regulators, such as the Food and Drug Administration, could water down Health Canada’s standards and open the door to reducing the number of scientific reviewers on staff.

Health Canada is planning to speed up reviews of some medications by piggybacking on the decisions of foreign regulators, including possibly the U.S. Food and Drug Administration, which has been in turmoil since Donald Trump returned to the White House a year ago.

Ottawa has not yet revealed which foreign drug authorities or which classes of drugs will be subject to the change, outlined in a draft ministerial order designed to quicken the pace of pharmaceutical approvals in Canada.

From The Globe and Mail via this RSS feed

you are viewing a single comment's thread
view the rest of the comments

[–] melsaskca@lemmy.ca 1 point 9 months ago

I have no problem with that as long as they follow the science. Doesn't matter who does the science as long as proper research methodologies are used.

permalink

fedilink

source